| Evidence-based strategies for clinical organizations to address COVID-19 vaccine hesitancy LJF Rutten, X Zhu, AL Leppin, JL Ridgeway, MD Swift, JM Griffin, ... Mayo Clinic Proceedings 96 (3), 699-707, 2021 | 320 | 2021 |
| Comparison of two highly-effective mRNA vaccines for COVID-19 during periods of Alpha and Delta variant prevalence A Puranik, PJ Lenehan, E Silvert, MJM Niesen, J Corchado-Garcia, ... MedRxiv, 2021 | 282 | 2021 |
| FDA-authorized mRNA COVID-19 vaccines are effective per real-world evidence synthesized across a multi-state health system C Pawlowski, P Lenehan, A Puranik, V Agarwal, AJ Venkatakrishnan, ... Med 2 (8), 979-992. e8, 2021 | 212* | 2021 |
| Pregnancy and birth outcomes after SARS-CoV-2 vaccination in pregnancy RN Theiler, M Wick, R Mehta, AL Weaver, A Virk, M Swift American journal of obstetrics & gynecology MFM 3 (6), 100467, 2021 | 186 | 2021 |
| Impact of the COVID-19 vaccine on asymptomatic infection among patients undergoing pre-procedural COVID-19 molecular screening AJ Tande, BD Pollock, ND Shah, G Farrugia, A Virk, M Swift, L Breeher, ... Clin Infect Dis 74 (1), 59-65, 2021 | 164* | 2021 |
| Effectiveness of mRNA COVID-19 vaccines against SARS-CoV-2 infection in a cohort of healthcare personnel MD Swift, LE Breeher, AJ Tande, CP Tommaso, CM Hainy, H Chu, ... Clinical Infectious Diseases: An Official Publication of the Infectious …, 2021 | 121* | 2021 |
| Analysis of the effectiveness of the Ad26. COV2. S adenoviral vector vaccine for preventing COVID-19 J Corchado-Garcia, D Zemmour, T Hughes, H Bandi, T Cristea-Platon, ... JAMA network open 4 (11), e2132540-e2132540, 2021 | 98 | 2021 |
| Strategies to achieve the healthy people 2020 annual influenza vaccine coverage goal for health-care personnel: recommendations from the national vaccine advisory committee NVA Committee Public Health Rep 128 (1), 7-25, 2013 | 69 | 2013 |
| Myocarditis following coronavirus disease 2019 mRNA vaccine: a case series and incidence rate determination Y Perez, ER Levy, AY Joshi, A Virk, M Rodriguez-Porcel, M Johnson, ... Clinical Infectious Diseases 75 (1), e749-e754, 2022 | 64 | 2022 |
| Real-time analysis of a mass vaccination effort confirms the safety of FDA-authorized mRNA COVID-19 vaccines R McMurry, P Lenehan, S Awasthi, E Silvert, A Puranik, C Pawlowski, ... Med 2 (8), 965-978. e5, 2021 | 58 | 2021 |
| A framework for sustainable contact tracing and exposure investigation for large health systems L Breeher, A Boon, C Hainy, MH Murad, C Wittich, M Swift Mayo Clinic Proceedings 95 (7), 1432-1444, 2020 | 45 | 2020 |
| Disparities in COVID-19 vaccine uptake among health care workers W Farah, L Breeher, V Shah, C Hainy, CP Tommaso, MD Swift Vaccine 40 (19), 2749-2754, 2022 | 41 | 2022 |
| Cerebral venous sinus thrombosis is not significantly linked to COVID-19 vaccines or non-COVID vaccines in a large multi-state health system C Pawlowski, J Rincón-Hekking, S Awasthi, V Pandey, P Lenehan, ... Journal of Stroke and Cerebrovascular Diseases 30 (10), 105923, 2021 | 40 | 2021 |
| Guidance for occupational health services in medical centers M Russi, WG Buchta, M Swift, LD Budnick, MJ Hodgson, D Berube, ... Journal of Occupational and Environmental Medicine 51 (11), e1-e18, 2009 | 34 | 2009 |
| Surveillance of safety of 3 doses of COVID-19 mRNA vaccination using electronic health records MJM Niesen, C Pawlowski, JC O’Horo, DW Challener, E Silvert, ... JAMA network open 5 (4), e227038-e227038, 2022 | 25 | 2022 |
| A comparison of 2 strategies to prevent infection following pertussis exposure in vaccinated healthcare personnel WP Goins, KM Edwards, CL Vnencak-Jones, MT Rock, M Swift, V Thayer, ... Clinical infectious diseases 54 (7), 938-945, 2012 | 25 | 2012 |
| Exposure to pulmonary tuberculosis in a neonatal intensive care unit: unique aspects of contact investigation and management of hospitalized neonates JJ Nania, J Skinner, K Wilkerson, JV Warkentin, V Thayer, M Swift, ... Infection Control & Hospital Epidemiology 28 (6), 661-665, 2007 | 25 | 2007 |
| Evaluation of healthcare personnel exposures to patients with severe acute respiratory coronavirus virus 2 (SARS-CoV-2) associated with personal protective equipment VP Shah, LE Breeher, CM Hainy, MD Swift Infection Control & Hospital Epidemiology 43 (6), 770-774, 2022 | 24* | 2022 |
| Comparative effectiveness of mRNA-1273 and BNT162b2 against symptomatic SARS-CoV-2 infection A Puranik, PJ Lenehan, E Silvert, MJM Niesen, J Corchado-Garcia, ... Med 3 (1), 28-41. e8, 2022 | 23 | 2022 |
| Healthcare personnel absenteeism, presenteeism, and staffing challenges during epidemics DW Challener, LE Breeher, JE Frain, MD Swift, PK Tosh, J O’Horo Infection Control & Hospital Epidemiology 42 (4), 388-391, 2021 | 21 | 2021 |
Laura E BreeherMayo ClinicVerified email at mayo.edu
